These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30407203)

  • 1. Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV.
    Fargher J; Reuter A; Furin J
    Curr Opin HIV AIDS; 2019 Jan; 14(1):21-27. PubMed ID: 30407203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of TB and HIV co-treatment: updates and insights.
    Tornheim JA; Dooley KE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):486-491. PubMed ID: 30080683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-associated tuberculosis: diagnostic and treatment challenges.
    El-Sadr WM; Tsiouris SJ
    Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis: burning issues: multidrug resistance and HIV-coinfection.
    Janbaz KH; Qadir MI; Ahmad B; Sarwar A; Yaqoob N; Masood MI
    Crit Rev Microbiol; 2012 Nov; 38(4):267-75. PubMed ID: 22421086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.
    Churchyard GJ; Scano F; Grant AD; Chaisson RE
    J Infect Dis; 2007 Aug; 196 Suppl 1():S52-62. PubMed ID: 17624827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice.
    De Cock KM; Grant A; Porter JD
    Lancet; 1995 Apr; 345(8953):833-6. PubMed ID: 7898232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of tuberculosis in people living with HIV.
    Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
    Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of TB/HIV co-infection: the state of the evidence.
    Torpey K; Agyei-Nkansah A; Ogyiri L; Forson A; Lartey M; Ampofo W; Akamah J; Puplampu P
    Ghana Med J; 2020 Sep; 54(3):186-196. PubMed ID: 33883764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    Loeliger A; Suthar AB; Ripin D; Glaziou P; O'Brien M; Renaud-Thery F; Crowley S; Williams B; Ridzon R; Granich R; Gilks C
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of drug-resistant tuberculosis among people living with HIV.
    Hurtado RM; Meressa D; Goldfeld AE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):478-485. PubMed ID: 30286039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment.
    Kay A; Garcia-Prats AJ; Mandalakas AM
    Curr Opin HIV AIDS; 2018 Nov; 13(6):501-506. PubMed ID: 30286040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.
    Mihret A; Bekele Y; Bobosha K; Kidd M; Aseffa A; Howe R; Walzl G
    J Infect; 2013 Apr; 66(4):357-65. PubMed ID: 23178506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive therapy for HIV-associated tuberculosis.
    Durovni B; Cavalcante S
    Curr Opin HIV AIDS; 2018 Nov; 13(6):507-511. PubMed ID: 30286041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of tuberculosis and HIV-1 co-infection.
    Schutz C; Meintjes G; Almajid F; Wilkinson RJ; Pozniak A
    Eur Respir J; 2010 Dec; 36(6):1460-81. PubMed ID: 20947678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New management approaches to tuberculosis in people living with HIV.
    Mhango DV; Mzinza DT; Jambo KC; Mwandumba HC
    Curr Opin Infect Dis; 2021 Feb; 34(1):25-33. PubMed ID: 33315751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.